Anthem Biosciences will launch on the stock market on Monday. Its IPO was heavily subscribed. The company raised Rs 3,396 crore. The issue price was Rs 570 per share. The IPO saw strong interest across all investor categories. Anthem operates across the drug development lifecycle. The company reported strong revenue and profit growth in FY25.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets